MDAI - NASDAQ

Spectral AI, Inc.

MDAI·NASDAQ

$1.94

-2.8%

HealthcareMedical - Devices

Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$61.74M

EPS-0.2900

P/E Ratio-6.69

Earnings Date08/11/2026

mdai

Free Cash Flow

Last Annual Value

-9.92M

3-Year CAGR

-104%

5-Year CAGR

-28%

10-Year CAGR

-13%

Adjust for Inflation

Spectral AI, Inc. Competitors Analysis of Free Cash Flow

MDAI · NASDAQ

Company	Free Cash Flow	CAGR 3Y	CAGR 5Y	CAGR 10Y
Spectral AI, Inc. NASDAQ:MDAI	-9.92M	N/A	N/A	N/A
Coeptis Therapeutics, Inc. NASDAQ:COEP	-8.60M	N/A	N/A	N/A
Century Therapeutics, Inc. NASDAQ:IPSC	-104.72M	N/A	N/A	N/A
Sensus Healthcare, Inc. NASDAQ:SRTS	332.00K	N/A	N/A	N/A
Equillium, Inc. NASDAQ:EQ	-22.79M	N/A	N/A	N/A
CAMP4 Therapeutics Corporation NASDAQ:CAMP	-29.83M	N/A	N/A	N/A
Gain Therapeutics, Inc. NASDAQ:GANX	-18.47M	N/A	N/A	N/A
Pulmonx Corporation NASDAQ:LUNG	-32.90M	N/A	N/A	N/A
Vivani Medical, Inc. NASDAQ:VANI	-25.49M	N/A	N/A	N/A
Karyopharm Therapeutics Inc. NASDAQ:KPTI	-75.37M	N/A	N/A	N/A
TELA Bio, Inc. NASDAQ:TELA	-28.67M	N/A	N/A	N/A

Spectral AI, Inc. Fair Value Envelope

MDAI · NASDAQ

Our analysis suggests that MDAI has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.94, this represents a potential HIDDEN relative to our calculated worth for Spectral AI, Inc..

HIDDEN

Intrinsic Value

Current Price: $1.94

Related Guides

Blog Categories

Continue your MDAI research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.